KEGG   PATHWAY: bom04934
Entry
bom04934                    Pathway                                
Name
Cushing syndrome - Bos mutus (wild yak)
Description
Cushing syndrome (CS) is a rare disorder resulting from prolonged exposure to excess glucocorticoids via exogenous and endogenous sources. The typical clinical features of CS are related to hypercortisolism and include accumulation of central fat, moon facies, neuromuscular weakness, osteoporosis or bone fractures, metabolic complications, and mood changes. Traditionally, endogenous CS is classified as adrenocorticotropic hormone (ACTH)-dependent (about 80%) or ACTH- independent (about 20%). Among ACTH-dependent forms, pituitary corticotroph adenoma (Cushing's disease) is most common. Most pituitary tumors are sporadic, resulting from monoclonal expansion of a single mutated cell. Recently recurrent activating somatic driver mutations in the ubiquitin-specific protease 8 gene (USP8) were identified in almost half of corticotroph adenoma. Germline mutations in MEN1 (encoding menin), AIP (encoding aryl-hydrocarbon receptor-interacting protein), PRKAR1A (encoding cAMP-dependent protein kinase type I alpha regulatory subunit) and CDKN1B (encoding cyclin-dependent kinase inhibitor 1B; also known as p27 Kip1) have been identified in familial forms of pituitary adenomas. However, the frequency of familial pituitary adenomas is less than 5% in patients with pituitary adenomas. Among ACTH-independent CS, adrenal adenoma is most common. Rare adrenal causes of CS include primary bilateral macronodular adrenal hyperplasia (BMAH) or primary pigmented nodular adrenocortical disease (PPNAD).
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
bom04934  Cushing syndrome
bom04934

Organism
Bos mutus (wild yak) [GN:bom]
Gene
102273696  CRH; corticotropin releasing hormone [KO:K05256]
102272695  CRHR1; corticotropin releasing hormone receptor 1 [KO:K04578]
102270917  CRHR2; corticotropin releasing hormone receptor 2 [KO:K04579]
102266153  guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas [KO:K04632]
102286123  neuroendocrine secretory protein 55 [KO:K04632]
102267116  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]
102274117  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]
102282732  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]
102286168  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]
102276460  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]
102265325  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]
102266966  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]
102272964  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]
102285642  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]
102281757  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
102269124  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
102281756  CREB1; cAMP responsive element binding protein 1 [KO:K05870]
102283891  ATF2; activating transcription factor 2 [KO:K04450]
102267423  ATF4; activating transcription factor 4 [KO:K04374]
102281505  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]
102268154  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]
102264680  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]
102271999  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]
102277321  CREB3; cAMP responsive element binding protein 3 [KO:K09048]
102275204  CREB5; cAMP responsive element binding protein 5 [KO:K09047]
102288212  ATF6B; activating transcription factor 6 beta [KO:K09049]
102272654  MEN1; menin 1 [KO:K14970]
102277921  ASH2L; ASH2 like histone lysine methyltransferase complex subunit [KO:K14964]
102282073  retinoblastoma-binding protein 5-like [KO:K14961]
102271359  RBBP5; RB binding protein 5, histone lysine methyltransferase complex subunit [KO:K14961]
102273992  WDR5B; WD repeat domain 5B [KO:K14963]
102264764  WDR5; WD repeat domain 5 [KO:K14963]
102280025  KMT2A; lysine methyltransferase 2A [KO:K09186] [EC:2.1.1.354]
102268887  KMT2D; lysine methyltransferase 2D [KO:K09187] [EC:2.1.1.354]
102272454  CDKN2C; cyclin dependent kinase inhibitor 2C [KO:K06622]
102284461  CDKN2A; cyclin dependent kinase inhibitor 2A [KO:K06621]
102278545  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
102264992  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
102270546  CCND1; cyclin D1 [KO:K04503]
102267169  RB1; RB transcriptional corepressor 1 [KO:K06618]
102274863  E2F1; E2F transcription factor 1 [KO:K17454]
102268181  E2F2; E2F transcription factor 2 [KO:K09389]
102270876  E2F3; E2F transcription factor 3 [KO:K06620]
102269724  RASD1; ras related dexamethasone induced 1 [KO:K07843]
102285228  GNAI3; G protein subunit alpha i3 [KO:K04630]
102274651  GNAI2; G protein subunit alpha i2 [KO:K04630]
102273920  GNAI1; G protein subunit alpha i1 [KO:K04630]
102265507  AHR; aryl hydrocarbon receptor [KO:K09093]
102279195  aryl hydrocarbon receptor [KO:K09093]
102284741  AIPL1; aryl hydrocarbon receptor interacting protein like 1 [KO:K17767]
102265539  AIP; aryl hydrocarbon receptor interacting protein [KO:K17767]
102287994  ARNT; aryl hydrocarbon receptor nuclear translocator [KO:K09097]
102276245  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]
102277344  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]
102284697  CCNE2; cyclin E2 [KO:K06626]
102271261  CCNE1; cyclin E1 [KO:K06626]
102268672  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]
102277590  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]
102271623  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]
102286805  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]
102272241  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]
102281822  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]
102271451  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]
102279381  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]
102280002  calcium/calmodulin-dependent protein kinase type II subunit delta [KO:K04515] [EC:2.7.11.17]
102286224  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]
102269967  ras-related protein Rap-1b-like [KO:K07836]
102265384  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]
102277019  ras-related protein Rap-1b-like [KO:K07836]
102278631  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]
102280670  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
102271710  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
102272368  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
102284931  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
102288141  NR4A1; nuclear receptor subfamily 4 group A member 1 [KO:K04465]
102269868  epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
102265401  USP8; ubiquitin specific peptidase 8 [KO:K11839] [EC:3.4.19.12]
102283767  POMC; proopiomelanocortin [KO:K05228]
102279724  MC2R; melanocortin 2 receptor [KO:K04200]
102280110  MRAP; melanocortin 2 receptor accessory protein [KO:K22398]
102267475  PDE8B; phosphodiesterase 8B [KO:K18437] [EC:3.1.4.53]
102277153  PDE8A; phosphodiesterase 8A [KO:K18437] [EC:3.1.4.53]
102282288  PDE11A; phosphodiesterase 11A [KO:K13298] [EC:3.1.4.17 3.1.4.35]
102286940  NR5A1; nuclear receptor subfamily 5 group A member 1 [KO:K08560]
102282294  SP1; Sp1 transcription factor [KO:K04684]
102275855  PBX1; PBX homeobox 1 [KO:K09355]
102280195  cytochrome P450 11B1, mitochondrial [KO:K00497] [EC:1.14.15.4]
102272939  cytochrome P450 11B1, mitochondrial-like [KO:K00497] [EC:1.14.15.4]
102270241  steroid 17-alpha-hydroxylase/17,20 lyase [KO:K00512] [EC:1.14.14.19 1.14.14.32]
102270532  steroid 17-alpha-hydroxylase/17,20 lyase [KO:K00512] [EC:1.14.14.19 1.14.14.32]
102277345  STAR; steroidogenic acute regulatory protein [KO:K16931]
102287389  NCEH1; neutral cholesterol ester hydrolase 1 [KO:K14349] [EC:3.1.1.-]
102278093  ARMC5; armadillo repeat containing 5 [KO:K22499]
102274045  AGT; angiotensinogen [KO:K09821]
102264884  AGTR1; angiotensin II receptor type 1 [KO:K04166]
102287414  GNAQ; G protein subunit alpha q [KO:K04634]
102287661  GNA11; G protein subunit alpha 11 [KO:K04635]
102264989  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]
102278948  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]
102273347  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]
102276260  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]
102269088  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]
102269013  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
102271039  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
102271922  KCNK2; potassium two pore domain channel subfamily K member 2 [KO:K04913]
102280279  CACNA1G; calcium voltage-gated channel subunit alpha1 G [KO:K04854]
102276868  CACNA1H; calcium voltage-gated channel subunit alpha1 H [KO:K04855]
102272298  CACNA1I; calcium voltage-gated channel subunit alpha1 I [KO:K04856]
102274230  ORAI1; ORAI calcium release-activated calcium modulator 1 [KO:K16056]
102282076  KCNA4; potassium voltage-gated channel subfamily A member 4 [KO:K04877]
102282634  KCNK3; potassium two pore domain channel subfamily K member 3 [KO:K04914]
102268224  LDLR; low density lipoprotein receptor [KO:K12473]
102284449  SCARB1; scavenger receptor class B member 1 [KO:K13885]
102282116  cholesterol side-chain cleavage enzyme, mitochondrial [KO:K00498] [EC:1.14.15.6]
102274088  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase [KO:K00070] [EC:1.1.1.145 5.3.3.1]
102267885  steroid 21-hydroxylase [KO:K00513] [EC:1.14.14.16]
102286958  FH; fumarate hydratase [KO:K01679] [EC:4.2.1.2]
102268143  WNT1; Wnt family member 1 [KO:K03209]
102285570  WNT2B; Wnt family member 2B [KO:K00182]
102288008  WNT2; Wnt family member 2 [KO:K00182]
102275609  WNT3A; Wnt family member 3A [KO:K00312]
102281377  WNT3; Wnt family member 3 [KO:K00312]
102269858  WNT4; Wnt family member 4 [KO:K00408]
102269211  WNT5A; Wnt family member 5A [KO:K00444]
102276467  WNT5B; Wnt family member 5B [KO:K00444]
102286828  WNT6; Wnt family member 6 [KO:K00445]
102279575  WNT7A; Wnt family member 7A [KO:K00572]
102284700  protein Wnt-7b-like [KO:K00572]
102287042  protein Wnt-7b [KO:K00572]
102285959  WNT8B; Wnt family member 8B [KO:K00714]
102285045  WNT8A; Wnt family member 8A [KO:K00714]
102278321  WNT9A; Wnt family member 9A [KO:K01064]
102283149  WNT9B; Wnt family member 9B [KO:K01064]
102276805  WNT10A; Wnt family member 10A [KO:K01357]
102267865  WNT10B; Wnt family member 10B [KO:K01357]
102266913  WNT11; Wnt family member 11 [KO:K01384]
102274851  WNT16; Wnt family member 16 [KO:K01558]
102269934  FZD1; frizzled class receptor 1 [KO:K02432]
102275255  FZD7; frizzled class receptor 7 [KO:K02432]
102277539  FZD2; frizzled class receptor 2 [KO:K02235]
102273339  FZD3; frizzled class receptor 3 [KO:K02329]
102286685  FZD4; frizzled class receptor 4 [KO:K02354]
102282966  FZD5; frizzled class receptor 5 [KO:K02375]
102276331  FZD8; frizzled class receptor 8 [KO:K02375]
102265247  FZD6; frizzled class receptor 6 [KO:K02376]
102267470  FZD10; frizzled class receptor 10 [KO:K02842]
102272449  FZD9; frizzled class receptor 9 [KO:K02842]
102273776  DVL2; dishevelled segment polarity protein 2 [KO:K02353]
102287954  DVL1; dishevelled segment polarity protein 1 [KO:K02353]
102280462  DVL3; dishevelled segment polarity protein 3 [KO:K02353]
102275260  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
102267637  AXIN1; axin 1 [KO:K02157]
102278168  AXIN2; axin 2 [KO:K04385]
102275011  CTNNB1; catenin beta 1 [KO:K02105]
102282143  APC2; APC2, WNT signaling pathway regulator [KO:K02085]
102272116  APC; APC, WNT signaling pathway regulator [KO:K02085]
102266633  TCF7; transcription factor 7 (T-cell specific, HMG-box) [KO:K02620]
102281039  TCF7L1; transcription factor 7 like 1 [KO:K04490]
102272230  TCF7L2; transcription factor 7 like 2 [KO:K04491]
102266946  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]
Compound
C00020  AMP
C00076  Calcium cation
C00187  Cholesterol
C00238  Potassium cation
C00410  Progesterone
C00575  3',5'-Cyclic AMP
C00735  Cortisol
C01176  17alpha-Hydroxyprogesterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01953  Pregnenolone
C05138  17alpha-Hydroxypregnenolone
C05488  11-Deoxycortisol
C07557  2,3,7,8-Tetrachlorodibenzodioxin
Reference
  Authors
Lacroix A, Feelders RA, Stratakis CA, Nieman LK
  Title
Cushing's syndrome.
  Journal
Lancet 386:913-27 (2015)
DOI:10.1016/S0140-6736(14)61375-1
Reference
  Authors
Xiong Q, Ge W
  Title
Gene mutations in Cushing's disease.
  Journal
Biomed Rep 5:277-282 (2016)
DOI:10.3892/br.2016.729
Reference
  Authors
Fukuoka H, Takahashi Y
  Title
The role of genetic and epigenetic changes in pituitary tumorigenesis.
  Journal
Neurol Med Chir (Tokyo) 54 Suppl 3:943-57 (2014)
DOI:10.2176/nmc.suppl.2014-3
Reference
  Authors
Quereda V, Malumbres M
  Title
Cell cycle control of pituitary development and disease.
  Journal
J Mol Endocrinol 42:75-86 (2009)
DOI:10.1677/JME-08-0146
Reference
  Authors
Caimari F, Korbonits M
  Title
Novel Genetic Causes of Pituitary Adenomas.
  Journal
Clin Cancer Res 22:5030-5042 (2016)
DOI:10.1158/1078-0432.CCR-16-0452
Reference
  Authors
Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P
  Title
Genetic mutations in sporadic pituitary adenomas--what to screen for?
  Journal
Nat Rev Endocrinol 11:43-54 (2015)
DOI:10.1038/nrendo.2014.181
Reference
  Authors
Hannah-Shmouni F, Faucz FR, Stratakis CA
  Title
Alterations of Phosphodiesterases in Adrenocortical Tumors.
  Journal
Front Endocrinol (Lausanne) 7:111 (2016)
DOI:10.3389/fendo.2016.00111
Reference
  Authors
Melmed S
  Title
Pathogenesis of pituitary tumors.
  Journal
Nat Rev Endocrinol 7:257-66 (2011)
DOI:10.1038/nrendo.2011.40
Reference
  Authors
Daly AF, Tichomirowa MA, Beckers A
  Title
Genetic, molecular and clinical features of familial isolated pituitary adenomas.
  Journal
Horm Res 71 Suppl 2:116-22 (2009)
DOI:10.1159/000192448
Reference
  Authors
Albani A, Theodoropoulou M, Reincke M
  Title
Genetics of Cushing's disease.
  Journal
Clin Endocrinol (Oxf) 88:3-12 (2018)
DOI:10.1111/cen.13457
Reference
  Authors
Duan K, Hernandez KG, Mete O
  Title
Clinicopathological correlates of adrenal Cushing's syndrome.
  Journal
Postgrad Med J 91:331-42 (2015)
DOI:10.1136/postgradmedj-2014-202612rep
Reference
  Authors
Drougat L, Espiard S, Bertherat J
  Title
Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?
  Journal
Eur J Endocrinol 173:M121-31 (2015)
DOI:10.1530/EJE-15-0532
Reference
  Authors
Stratakis CA, Boikos SA
  Title
Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.
  Journal
Nat Clin Pract Endocrinol Metab 3:748-57 (2007)
DOI:10.1038/ncpendmet0648
Reference
  Authors
Refojo D, Holsboer F
  Title
CRH signaling. Molecular specificity for drug targeting in the CNS.
  Journal
Ann N Y Acad Sci 1179:106-19 (2009)
DOI:10.1111/j.1749-6632.2009.04983.x
Reference
  Authors
Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E
  Title
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.
  Journal
Mol Endocrinol 16:1638-51 (2002)
DOI:10.1210/mend.16.7.0863
Reference
  Authors
Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J
  Title
Cushing's syndrome variants secondary to aberrant hormone receptors.
  Journal
Trends Endocrinol Metab 15:375-82 (2004)
DOI:10.1016/j.tem.2004.08.007
Reference
  Authors
Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M
  Title
Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
  Journal
Nat Genet 47:31-8 (2015)
DOI:10.1038/ng.3166
Reference
  Authors
Kaiser UB
  Title
Cushing's disease: towards precision medicine.
  Journal
Cell Res 25:649-50 (2015)
DOI:10.1038/cr.2015.53
Reference
  Authors
Uzilov AV, Cheesman KC, Fink MY, Newman LC, Pandya C, Lalazar Y, Hefti M, Fowkes M, Deikus G, Lau CY, Moe AS, Kinoshita Y, Kasai Y, Zweig M, Gupta A, Starcevic D, Mahajan M, Schadt EE, Post KD, Donovan MJ, Sebra R, Chen R, Geer EB
  Title
Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.
  Journal
Cold Spring Harb Mol Case Stud 3:a001602 (2017)
DOI:10.1101/mcs.a001602
Reference
  Authors
Huang C, Shi Y, Zhao Y
  Title
USP8 mutation in Cushing's disease.
  Journal
Oncotarget 6:18240-1 (2015)
DOI:10.18632/oncotarget.4856
Reference
  Authors
Theodoropoulou M, Reincke M, Fassnacht M, Komada M
  Title
Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
  Journal
Eur J Endocrinol 173:M73-83 (2015)
DOI:10.1530/EJE-15-0320
Reference
  Authors
Yu L, Zhang J, Guo X, Chen X, He Z, He Q
  Title
ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.
  Journal
PLoS One 13:e0191602 (2018)
DOI:10.1371/journal.pone.0191602
Reference
  Authors
Wu X, Hua X
  Title
Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.
  Journal
Curr Mol Med 8:805-15 (2008)
DOI:10.2174/156652408786733702
Reference
  Authors
Ozfirat Z, Korbonits M
  Title
AIP gene and familial isolated pituitary adenomas.
  Journal
Mol Cell Endocrinol 326:71-9 (2010)
DOI:10.1016/j.mce.2010.05.001
Related
pathway
bom00020  Citrate cycle (TCA cycle)
bom00140  Steroid hormone biosynthesis
bom04020  Calcium signaling pathway
bom04024  cAMP signaling pathway
bom04110  Cell cycle
bom04310  Wnt signaling pathway
bom04927  Cortisol synthesis and secretion
bom04960  Aldosterone-regulated sodium reabsorption
KO pathway
ko04934   
LinkDB

DBGET integrated database retrieval system